MBOT vs. KRMD, TLSI, INFU, STIM, SGHT, ECOR, ZJYL, LNSR, PDEX, and TELA
Should you be buying Microbot Medical stock or one of its competitors? The main competitors of Microbot Medical include KORU Medical Systems (KRMD), TriSalus Life Sciences (TLSI), InfuSystem (INFU), Neuronetics (STIM), Sight Sciences (SGHT), electroCore (ECOR), Jin Medical International (ZJYL), LENSAR (LNSR), Pro-Dex (PDEX), and TELA Bio (TELA). These companies are all part of the "medical equipment" industry.
Microbot Medical vs.
Microbot Medical (NASDAQ:MBOT) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their community ranking, valuation, earnings, dividends, institutional ownership, profitability, analyst recommendations, risk and media sentiment.
16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are owned by institutional investors. 10.5% of Microbot Medical shares are owned by insiders. Comparatively, 25.6% of KORU Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Microbot Medical received 304 more outperform votes than KORU Medical Systems when rated by MarketBeat users. Likewise, 70.73% of users gave Microbot Medical an outperform vote while only 63.77% of users gave KORU Medical Systems an outperform vote.
Microbot Medical has higher earnings, but lower revenue than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.
In the previous week, Microbot Medical had 1 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for Microbot Medical and 2 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 0.93 beat Microbot Medical's score of 0.37 indicating that KORU Medical Systems is being referred to more favorably in the news media.
Microbot Medical has a beta of 1.51, indicating that its share price is 51% more volatile than the S&P 500. Comparatively, KORU Medical Systems has a beta of 0.45, indicating that its share price is 55% less volatile than the S&P 500.
Microbot Medical has a net margin of 0.00% compared to KORU Medical Systems' net margin of -37.42%. KORU Medical Systems' return on equity of -24.60% beat Microbot Medical's return on equity.
Microbot Medical currently has a consensus price target of $9.00, suggesting a potential upside of 579.25%. KORU Medical Systems has a consensus price target of $4.70, suggesting a potential upside of 44.44%. Given Microbot Medical's higher probable upside, equities research analysts clearly believe Microbot Medical is more favorable than KORU Medical Systems.
Summary
KORU Medical Systems beats Microbot Medical on 9 of the 17 factors compared between the two stocks.
Get Microbot Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MBOT and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Microbot Medical Competitors List
Related Companies and Tools
This page (NASDAQ:MBOT) was last updated on 3/4/2025 by MarketBeat.com Staff
